Glutathione triggered degradation of polydopamine to facilitate controlled drug release for synergic combinational cancer treatment
Abstract
Here we report a novel mechanism for triggering drug release in the polydopamine (PDA)-coated magnetic CuCo2S4 core–shell nanostructure by glutathione (GSH) triggered degradation of PDA for release.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2019
- Source ID
- 10.1039/c9tb01400d
Entities
People
- An-qi Zheng
- Jian-Hua Wang
- Omar Johnson
- Ting-ting Guo
- Wei Chen
- Ya-nan Hao
- Yang Shu
Organizations
- National Cancer Institute
- National Institutes of Health
- National Natural Science Foundation of China
- Northeastern University
- United States Army
- University of Texas at Arlington
- Yusuf Hamied Department of Chemistry